Listen Score
LS 29
Global Rank
TOP 10%

ABOUT THIS PODCAST 🔗

Update frequency:
every 50 days
Average audio length:
39 minutes
Guest interviews
Has sponsors
English
United States
64 episodes
since May 26, 2021
episodic

AUDIENCE OF THIS PODCAST 🔗

~74.90% of listeners are from United States.
🇺🇸
US
74.90%
🇬🇧
GB
5.32%
🇽🇰
XK
4.18%
🇮🇳
IN
3.04%
🇮🇹
IT
1.90%
🇵🇭
PH
1.52%
🇪🇸
ES
1.52%
🇩🇪
DE
1.52%
🇰🇷
KR
0.76%
🇫🇷
FR
0.76%
🇸🇪
SE
0.76%
🇨🇦
CA
0.76%
🇹🇷
TR
0.38%
🇦🇷
AR
0.38%
🇵🇷
PR
0.38%
🇦🇺
AU
0.38%
🇮🇪
IE
0.38%
🇰🇪
KE
0.38%
🇯🇵
JP
0.38%
🇮🇱
IL
0.38%
Others
0.02%
* Data source: directly measured on Listen Notes. real-time

LATEST EPISODE 🔗

Matthew "Oki" O'Connor is the CEO of Scientific Affairs at Cyclarity Therapeutics, a clinical-stage biotech building a new class of medicines designed not to slow the accumulation of vascular damage but to reverse it. Oki and Chris first crossed paths as postdocs at Lawrence Berkeley National Lab i…

SEARCH PAST EPISODES

Search past episodes of Translating Aging.

PREVIOUS EPISODES

Marco Quarta is co-founder and Chief Scientific Officer of Rubedo Life Sciences, a precision-therapeutics company developing medicines that target the pathological cell states that drive age-associated disease. Marco's first appearance on the show was three years ago, in February 2023 (Episode 35),…
Sergey Jakimov is the Managing Partner and co-founder of LongeVC, one of Europe's most active longevity-focused venture capital firms, currently raising its second fund targeting $250 million. In this episode, Chris and Sergey explore the investment landscape shaping longevity biotechnology today. …
In this special episode, host Chris Patil (VP-Media, BioAge) moderates a live panel discussion at the 25th Bay Area Aging Meeting at UCSF, bringing together six leading voices across the aging research ecosystem to tackle one of the field's most critical challenges: how to move promising discoverie…
Michael Ringel is the Chief Operating Officer of Life Biosciences, a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging. Michael became COO of Life just a few months ago, but he's been advising the company since 2018. Prior to this yea…
Dr. Janine Sengstack is the Chief Scientific Officer and co-founder of Junevity, a company created in 2023 with the mission of extending health span and lifespan through what they term "Cell Reset therapeutics." The company recently secured $10 million in seed funding. In this episode, Chris and Ja…
Dr. Andrew Brack, Program Manager at the Advanced Research Projects Agency for Health (ARPA-H), discusses PROSPR (Proactive Solutions for Prolonging Resilience), an ambitious new program aimed at extending human healthspan. In this wide-ranging conversation, Chris and Andrew explore how PROSPR plan…
Markus Gstöttner is the CEO of Clock.bio, a company devoted to extending and improving the quality of life by reversing the harmful effects of time in our cells. In this episode, Gstöttner shares how his company is working to extend healthspan by understanding and harnessing the natural rejuvenati…
Adam Freund (CEO) and Remi Laberge (CTO) are the founders of Arda Therapeutics, a biotechnology company developing novel therapies that selectively eliminate harmful cell populations driving chronic diseases. In this episode, they discuss their innovative approach to treating conditions like idiopa…
Alex Aravanis is the CEO and co-founder of Moonwalk Biosciences, a biotechnology company pioneering precision epigenetic medicines. In this episode, Chris and Alex discuss Moonwalk's innovative approach to developing a new class of medicines aimed at treating complex diseases and potentially extend…
Disclaimer: The podcast and artwork embedded on this page are from BioAge Labs, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.